← Leaderboards
Arnold S Monto
University Of Michigan At Ann Arbor
$34,807,923
Attributed
$36,080,468
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
CDC$29,224,202 · 6
NIH$6,856,266 · 3
By mechanism
U01$29,405,678 · 6
U18$4,129,699 · 1
R01$1,970,943 · 1
R56$574,148 · 1
Top collaborators
- Suzanne Ohmit5 shared
- Aubree L Gordon1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Jennifer S Barber$6,136,992
- Eric J Tchetgen$10,512,891
- Jonathan L Zelner$5,992,666
- Matthew J Elrick$1,572,559
- Pamela Tinmoi Wong$1,927,527
Others in their field
Top investigators on “Predisposition”
- David Heimbrook · Leidos Biomedical Research, Inc.$117,485,565
- Barton F Haynes · Duke University$92,250,940
- James D Crapo · University Of Colorado Denver$80,593,932
- Lisa P Jacobson · Johns Hopkins University$75,790,474
- Robert O Wright · Brigham And Women'S Hospital$69,807,797
- John A Tainer · Scripps Research Institute$66,234,437
Research focus
PredispositionRespiratory Tract InfectionsInfluenza VaccinationLongitudinal StudiesHouseholdRespiratoryIncidenceInfluenzaAccountingLaboratoriesFlu TransmissionBaseAntibodiesReportingAdultCommunitiesBlood SpecimenInfectionCharacteristicsChildImmune ResponseCohortAffectRespiratory Virus
Grant awards (36)
US Influenza Vaccine Effectiveness Network$2,999,990
U01 · FY2020 · IP · contact PI
US Influenza Vaccine Effectiveness Network$1,799,998
U01 · FY2019 · IP · contact PI
US Hospital Vaccine Effectiveness (VE) Network$829,998
U01 · FY2019 · IP · contact PI
US Influenza Vaccine Effectiveness Network$799,995
U01 · FY2019 · IP · contact PI
US Hospital Vaccine Effectiveness (VE) Network - Supplement$706,839
U01 · FY2019 · IP · contact PI
US Hospital Vaccine Effectiveness (VE) Network$499,999
U01 · FY2019 · IP · contact PI
US Influenza Vaccine Effectiveness Network$1,799,999
U01 · FY2018 · IP · contact PI
US Hospital Vaccine Effectiveness (VE) Network$899,998
U01 · FY2018 · IP · contact PI
US Influenza Vaccine Effectiveness Network$1,299,999
U01 · FY2017 · IP · contact PI
US Hospital Vaccine Effectiveness (VE) Network$649,797
U01 · FY2017 · IP · contact PI
US Influenza Vaccine Effectiveness Network$1,299,999
U01 · FY2016 · IP · contact PI
Household Studies of Influenza and Other Respiratory Viruses$574,148
R56 · FY2016 · AI · contact PI
US Hospital Vaccine Effectiveness (VE) Network$552,432
U01 · FY2016 · IP · contact PI
US Hospital Vaccine Effectiveness (VE) Network$30,902
U01 · FY2016 · IP · contact PI
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research$1,413,786
U01 · FY2015 · IP · contact PI
Household Studies of Influenza and Other Respiratory Viruses$533,162
R01 · FY2015 · AI · contact PI
US Hospital Vaccine Effectiveness (VE) Network$300,000
U01 · FY2015 · IP · contact PI
Household Studies of Influenza and Other Respiratory Viruses - Supplement: EV D68 Surveillance$26,581
R01 · FY2015 · AI · contact PI
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research$1,545,000
U01 · FY2014 · IP · contact PI
Household Studies of Influenza and Other Respiratory Viruses$480,000
R01 · FY2014 · AI · contact PI
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research$1,085,000
U01 · FY2013 · IP · contact PI
Household Studies of Influenza and Other Respiratory Viruses$451,200
R01 · FY2013 · AI · contact PI
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research$1,085,000
U01 · FY2012 · IP · contact PI
Household Studies of Influenza and Other Respiratory Viruses$480,000
R01 · FY2012 · AI · contact PI
A Randomized Study of Exclusion Criteria in a University Population$1,999,963
U01 · FY2011 · CK · contact PI
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research$1,084,999
U01 · FY2011 · IP · contact PI
Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Con$1,138,296
U18 · FY2010 · IP · contact PI
Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Con$748,549
U18 · FY2010 · IP · contact PI
Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Con$1,492,854
U18 · FY2009 · IP · contact PI
Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Con$750,000
U18 · FY2008 · IP · contact PI
Reducing Transmission of Influenza by Face Masks$181,000
U01 · FY2008 · CI · contact PI
Reducing Transmission of Influenza by Face Masks$1,128,794
U01 · FY2007 · CI · contact PI
Comparative Study of Influenza Vaccines in Adults$1,482,290
U01 · FY2006 · AI · contact PI
Reducing Transmission of Influenza by Face Masks$1,101,016
U01 · FY2006 · CI · contact PI
Comparative Study of Influenza Vaccines in Adults$1,589,316
U01 · FY2005 · AI
Comparative Study of Influenza Vaccines in Adults$1,239,569
U01 · FY2004 · AI